LNTH Return on Tangible Equity | Lantheus Holdings, Inc.

Lantheus Holdings, Inc. (LNTH) Return on Tangible Equity

2026-06-30: Return Tang Equity 43.53%.
2026-03-31: Return Tang Equity 54.09%.
2025-12-31: Return Tang Equity 62.03%.
2025-09-30: Return Tang Equity 43.15%.

Complete source-backed return tang equity history.

Available history: 2017-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	43.53%
2026-03-31	54.09%
2025-12-31	62.03%
2025-09-30	43.15%
2025-06-30	32.07%
2025-03-31	26.79%
2024-12-31	36.12%
2024-09-30	45.25%
2024-06-30	54.01%
2024-03-31	62.04%
2023-12-31	54.20%
2023-09-30	21.95%
2023-06-30	12.34%
2023-03-31	-10.76%
2022-12-31	32.52%
2022-09-30	39.80%
2022-06-30	17.06%
2022-03-31	-28.69%
2021-12-31	-101.28%
2021-09-30	-35.57%
2021-06-30	-28.20%
2021-03-31	-3.20%
2020-12-31	-5.91%
2020-09-30	0.18%
2020-06-30	5.31%
2020-03-31	26.17%
2019-12-31	34.59%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	62.03%
2024-12-31	36.12%
2023-12-31	54.20%
2022-12-31	32.52%
2021-12-31	-101.28%
2020-12-31	-5.91%
2019-12-31	34.59%
2018-12-31	87.79%
2017-12-31	-2923.12%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
NEOGEN CORP (NEOG)	United States	$2.979B	-247.49
Celldex Therapeutics, Inc. (CLDX)	United States	$2.471B	-9.72
Intellia Therapeutics, Inc. (NTLA)	United States	$1.705B	-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)	United States	$0.806B	-5.88
QuidelOrtho Corp (QDEL)	United States	$0.733B	-0.90
Alpha Teknova, Inc. (TKNO)	United States	$0.500B	-18.12
MYRIAD GENETICS INC (MYGN)	United States	$0.397B	-4.84
Insight Molecular Diagnostics Inc. (IMDX)	United States	$0.129B	-3.90
IMMUCELL CORP /DE/ (ICCC)	United States	$0.091B	116.10
BIOMERICA INC (BMRA)	United States	$0.011B